Xue Li

机构：North Sichuan Medical University, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Wuhan University, Jiaxing University, First Affiliated Hospital of Guangzhou Medical University, Ministry of Education, Qilu Hospital of Shandong University, University of Chinese Academy of Sciences, Shenzhen Third People’s Hospital, Molecular Sciences Institute, Luoyang Institute of Science and Technology, Hubei University, Xi'an Jiaotong University, Guangzhou Medical University · ORCID：0000-0001-9793-8844

发表论文 30 篇 · 总被引 547 次 · h-index 8

代表论文

• Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer (2013 · Oncogene · 被引 231)
• A versatile flexible film containing phase change microcapsules and polypyrrole/bacterial cellulose with high enthalpy, photothermal and Joule heating for personal thermal management (2025 · Chemical Engineering Journal · 被引 79)
• A peptide-centric local stability assay enables proteome-scale identification of the protein targets and binding regions of diverse ligands (2024 · Nature Methods · 被引 79)
• Napabucasin, a novel inhibitor of STAT3, inhibits growth and synergises with doxorubicin in diffuse large B-cell lymphoma (2020 · Cancer Letters · 被引 32)
• Semaphorin 4D is a potential biomarker in pediatric leukemia and promotes leukemogenesis by activating PI3K/AKT and ERK signaling pathways (2021 · Oncology Reports · 被引 29)
• Secreted recombinant human IL-24 protein inhibits the proliferation of esophageal squamous cell carcinoma Eca-109 cells in vitro and in vivo (2016 · Oncology Reports · 被引 17)